Citadel Advisors - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$11,646
-51.5%
105,397
-27.0%
0.00%
Q3 2022$24,000
-57.1%
144,300
-35.2%
0.00%
Q2 2022$56,000
-55.6%
222,657
-6.0%
0.00%
Q1 2022$126,000
-84.1%
236,873
-81.6%
0.00%
Q4 2021$794,000
+62.4%
1,289,511
+169.1%
0.00%
Q3 2021$489,000
-57.4%
479,197
-23.5%
0.00%
Q2 2021$1,147,000
-7.5%
626,624
-0.4%
0.00%
Q1 2021$1,240,000
+174.3%
629,000
+73.7%
0.00%
Q4 2020$452,000
-66.1%
362,097
-51.2%
0.00%
Q3 2020$1,335,000
-91.4%
741,600
-60.0%
0.00%
-100.0%
Q2 2020$15,559,000
+108.7%
1,854,347
+30.3%
0.01%
+66.7%
Q1 2020$7,456,000
+2215.5%
1,423,070
+2318.6%
0.00%
Q4 2019$322,000
+10.7%
58,839
-1.6%
0.00%
Q3 2019$291,000
-54.2%
59,800
-34.7%
0.00%
Q2 2019$635,000
-75.4%
91,600
-75.4%
0.00%
-100.0%
Q1 2019$2,584,000
+89.4%
371,801
+59.2%
0.00%
Q4 2018$1,364,000
+76.2%
233,483
+127.9%
0.00%
Q3 2018$774,000
+96.9%
102,463
+32.1%
0.00%
Q2 2018$393,000
+1.8%
77,588
+22.4%
0.00%
Q1 2018$386,000
+49.0%
63,380
+73.3%
0.00%
Q4 2017$259,000
+137.6%
36,562
+139.0%
0.00%
Q3 2017$109,000
-73.9%
15,300
-76.9%
0.00%
Q2 2017$417,000
-58.4%
66,295
-45.4%
0.00%
Q1 2017$1,003,000
+3034.4%
121,501
+1038.0%
0.00%
Q2 2016$32,000
+88.2%
10,677
+4.1%
0.00%
Q4 2015$17,00010,2560.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders